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Walking purposefully towards the shab-
by grey concrete structure that functions
as the main health centre of Kyenjojo
district in western Uganda, public health
doctor Andrew Byamungu makes a trip he
has done many times before since joining
the vector control department of the
Ugandan Ministry of Health. Fighting his
way through the crowds of waiting pa-
tients and relatives, he greets the tired-
looking health staff who, among their
many other duties, are responsible for
education and drug distribution in the
country’s onchocerciasis control pro-
gramme, which is one of the most
advanced of the 19 country projects of
the African Programme for Onchocercia-
sis Control (APOC).
After a brief exchange with the long-
serving nurse-cum-midwife, Dr Byamungu
explains that the health centre staff want
to know if this time he is accompanied by
the programme’s personable director,
Uche Amazigo (Image 1), whose innumer-
able visits to APOC’s project sites—from
Uganda’s bustling west to remote moun-
tain villages in Cameroon—are just one of
the reasons her programme has been
lauded as the most successful public health
effort in Africa. ‘‘Everyone knows Ama-
zigo,’’ he says with a chuckle.
A soft-spoken, elegant woman in her
fifties, Dr Amazigo, who became director
of APOC in 2005, developed an interest in
onchocerciasis—known colloquially as riv-
er blindness because of its most destructive
symptom—as she began to learn about the
social consequences of the disease from
women she met as a result of regular trips
into Nigeria’s rural southeast. Working as
a lecturer on tropical diseases in the
university town of Nsukka in the late
1970s, Dr Amazigo had a chance encoun-
ter with a pregnant woman who was
plagued by the disease’s characteristic
itchy lesions and striking depigmentation,
and whose husband had left her due to
these disfiguring effects.
Moved and deeply saddened by the
woman’s predicament, Dr Amazigo re-
solved to help pay for her treatment and to
learn more about how the disease de-
stroyed lives. She enrolled in a local rural
women’s group to hear firsthand about the
consequences of onchocerciasis, a parasitic
infection transmitted through the bite of
the blackfly, on important life experiences
such as marriage and breast feeding. And,
around the same time, she contacted the
head of the WHO-associated Special
Programme for Research and Training
in Tropical Diseases (TDR) and was
encouraged to apply for a grant to study
the disease properly. She took up the offer,
and her research has since helped change
international perceptions about the mor-
bidity associated with onchocerciasis.
WHO has repeated Dr Amazigo’s studies
in several other countries, and this data
formed the scientific basis for launching
APOC in 1995, which Dr Amazigo was
invited to join as a scientist in 1996.
APOC’s strategy is based on preventive
treatment of affected populations with a
once-yearly dose of the anti-onchocerciasis
drug ivermectin. Thanks to an unlimited
donation of the agent by its manufacturer,
Merck & Co., APOC’s main task has been
to work out a way to deliver the treatment
to communities in a sustainable and long-
term manner. The strategy that has made
APOC so successful—one that Dr Ama-
zigo helped develop while working as a
scientist at TDR—uses unpaid community
workers to supplement the health system
by training them to treat themselves and
their neighbours and to complete record
books to track drug distribution. ‘‘All the
communities want is for you to come and
train their own chosen people. Once you
have trained them, you send drugs to the
drop-off point, and they will complete
drug registers and return them,’’ Dr
Amazigo enthuses. ‘‘Communities do the
job that the health system should do, but
the important thing is that we do it in a
way that will make communities feel very
proud to be doing it—that they are able to
distribute drugs themselves—and proud to
serve the community.’’
Across 19 sub-Saharan African coun-
tries, the remarkable successes achieved by
APOC and its less extensive predecessor
programme, Onchocerciasis Control Pro-
gramme (OCP), which focused on 11
countries in West Africa, show that Dr
Amazigo’s long-term support for this
strategy is not misplaced. ‘‘You now have
countries where onchocerciasis is no
longer a public health problem,’’ she says.
‘‘In Burkina Faso, Mali, Senegal, Niger,
Guinea, Togo, and Benin it is very hard to
find any child going blind from oncho
because they have active national surveil-
lance which has maintained the achieve-
ments of the OCP.’’ Some of these
countries have also started to reclaim land
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blackfly to grow cotton on a large scale.
‘‘Some are up to the level of exporting
cotton, so this is a huge economic
development,’’ adds Dr Amazigo.
As APOC’s mandate nears its pre-
defined endpoint of 2015, Dr Amazigo is
now turning her attentions to a new and
potentially more ambitious challenge.
Using the community-directed treatment
strategy APOC has refined, she is now
adamant that the programme should
become a model for a more general
strengthening of health systems in African
countries. APOC’s experience shows that
the system can work, successfully and
sustainably, even in the most difficult
environments, such as the conflict-scarred
and poverty-stricken Democratic Republic
of Congo. What is more, says Dr Amazigo,
research done during APOC’s 10-year
operational period shows that community
volunteers could actually be more effective
than the health system, producing better
results and much higher treatment cover-
age.
For Dr Amazigo, integrating APOC’s
activities with the health system is her
opportunity to leave a lasting legacy, in the
shape of improved health services for
hundreds of thousands of people. In some
countries, notably Dr Byamungu’s domain
in Uganda, the process has already begun.
Community volunteers recruited for
APOC are also delivering vitamin A,
deworming treatments, and home-based
malaria care to their charges since the
Ministry of Health adopted APOC’s
strategy as a model for delivering other
simple primary health care interventions
in an integrated way. And with the high-
level endorsement of WHO Director
General Margaret Chan, who told dele-
gates at the 1st Neglected Tropical
Diseases Global Meeting of Partners in
Geneva in April 2007 that the legacy of
onchocerciasis control in Africa was a
prime example of the vertical-to-horizon-
tal transition of health programmes that is
necessary to make control strategies sus-
tainable in countries with weak health
systems, Dr Amazigo is hopeful more will
follow.
‘‘Given the lack of human resources,
particularly at the peripheral level, how
many doctors would like to go and live in a
sub-district area? How many nurses are
there? Very few. The way to go is to bring
the communities to be part of health
services,’’ Dr Amazigo explains. But there
is a drawback: community-directed treat-
ment needs patience, time, and commit-
ment. These qualities are often in short
supply when it comes to health pro-
gramme managers focused on short-term
results. ‘‘Some people want quick results
and so they don’t have the patience to
implement the process,’’ she laments. ‘‘I
am not saying it is easy, but I am
convinced that this is the way forward.’’
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